Republicans in Congress echo the message. In a Fox News interview on Sunday, Sen. Roger Marshall, R-Kan., explained that nonmedical issues are driving the country’s high rates of chronic diseases, ...

Announcement of the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final ...

Big tech will keep investing in the health care market, but nothing can replace a physician in the room with a patient.

Ons Jabeur revealed that she suffered a mid-match asthma attack after a scary Australian Open scene and was on the verge of ...

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

The Washington Post: Society Is Making You Sick, GOP Says. Too Bad Their Plans Will Make You Sicker. The biggest threat to your health isn’t your inability to afford an inhaler or to get that ...

When designing and developing electronic medical devices for users who may be in pain, under duress, or untrained, the goal ...

The Food and Drug Administration’s (FDA or Agency) final rule on Additional Conditions for Nonprescription Use (ACNU) paves the way for some ...

Inhaled insulin was noninferior to usual care in glycemic control outcomes after 17 weeks among patients with type 1 diabetes.

"We felt we needed to do something in Rachel's memory and if we can save a life we've done, and Rachel has done, something to ...

For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...